MARIAM BOUANANE-SMITH: Open Payments
NPI 1053024026 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 14 payments from 6 companies in 2025. Trend: 2023 $822 · 2024 $2,519 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $169 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Alkermes, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, TRINTELLIX, REXULTI, COBENFY, ABILIFY MAINTENA, ARISTADA, LYBALVI, CAPLYTA.
Industry payments across VA — which companies pay providers there.
